
The American College of Rheumatology (ACR) and EULAR collaborated to develop new antiphospholipid syndrome (APS) classification criteria. These criteria include a positive antiphospholipid antibody test entry criterion within 3 years of an associated clinical criterion, followed by weighted criteria in clinical and laboratory domains. The new criteria demonstrated 99% specificity and 84% sensitivity in validation.
Like
Save
Share